provider
Search result for "Solr search content"
Search Result for "*:*"
provider
Roberto Martinez, MD Breast Reconstructive Surgery, Plastic Surgery
provider
Rachel Adler, PhD, APRN, PMHNP-BC, AGNP-C Psycho-Oncology, Adult Psychiatry
provider
provider
Katherine Cermin, DNP, APRN, FNP-BC, FNP-C Family Nurse Practitioner, Oncology Survivorship
provider
Debra Kent, DNP, MSN, APRN-PC, RN Pediatric Nurse Practitioner, Oncology Survivorship
provider
Alexander Parikh, MD, MPH, FACS, FSSO Surgical Oncology, Hepatobiliary and Pancreas Surgery
provider
provider
Valerie Shiu, MD Mohs Micrographic Surgery, Dermatology
Clinical Trial
A Phase II multicenter, open-label, single-arm dose escalation study of Asciminib monotherapy in 2nd and 1st Line Chronic Phase – Chronic Myelogenous Leukemia (ASC2ESCALATE) (CTMS# 23-0101)
This will be a multicenter Phase II open-label study of asciminib in CML-CP patients who have been previously treated with one prior ATP-binding site TKI with discontinuation due to treatment failure, warning, or intolerance. (2L patient cohort). In addition, newly diagnosed CML-CP patients who may have received up to 4 weeks of prior TKI are included in a separate 1L patient cohort.